products

Anexate® (flumazenil)

Anexate® (flumazenil)

In October 2016, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Anexate (flumazenil) to Pharmaco (Australia) Limited within Australia.

The current Consumer Medicine Information (CMI) and Product Information (PI) for Anexate are available from the Therapeutic Goods Administration (TGA) website at: https://www.ebs.tga.gov.au/